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Metazoan evolution involves increasing protein
domain complexity, but how this relates to control
of biological decisions remains uncertain. The Ras
guanine nucleotide exchange factor (RasGEF) Sos1
and its adaptor Grb2 are multidomain proteins that
couple fibroblast growth factor (FGF) signaling to
activation of the Ras-Erk pathway duringmammalian
development and drive embryonic stem cells toward
the primitive endoderm (PrE) lineage. We show that
the ability of Sos1/Grb2 to appropriately regulate plu-
ripotency and differentiation factors and to initiate
PrE development requires collective binding of
multiple Sos1/Grb2 domains to their protein and
phospholipid ligands. This provides a cooperative
system that only allows lineage commitment when
all ligand-binding domains are occupied. Further-
more, our results indicate that the interaction
domains of Sos1 and Grb2 have evolved so as to
bind ligands not with maximal strength but with
specificities and affinities that maintain cooperativ-
ity. This optimized system ensures that PrE lineage
commitment occurs in a timely and selective manner
during embryogenesis.INTRODUCTION
Metazoan signaling proteins frequently contain multiple modular
domains, each with individual binding or enzymatic functions. A
comparison of eukaryotic proteomes suggests that linking
diverse domains in new combinations has yielded novel cellular1008 Cell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc.functions required for metazoan evolution (Jin et al., 2009; Lim
and Pawson, 2010). For example, the juxtaposition of distinct
interaction domains, as in the case of adaptor proteins, can
form new signaling pathways (Howard et al., 2003), whereas
combining interaction and catalytic domains can target an
enzyme to specific substrates (Mayer et al., 1995) and facilitate
intramolecular interactions that regulate catalytic activity (Fili-
ppakopoulos et al., 2008; Sicheri et al., 1997). Furthermore,
a protein containing several interaction domains can be coupled
to multiple inputs that act either separately or synergistically to
regulate signaling (Carnegie et al., 2009; Prehoda et al., 2000).
Although the individual functions of specific domains are well
understood, we are more poorly informed about those proper-
ties of interaction and catalytic domains that allow them to act
cooperatively in mediating complex biological processes, such
as the timing and specificity of cell-fate decisions in the
mammalian embryo. Determining the physiological relevance
of the multidomain architecture of signaling proteins requires
that they are studied in a proper biological context. To this
end, we have exploited the critical roles of Son of Sevenless 1
(Sos1), a guanine nucleotide exchange factor (GEF) for the
Ras GTPase, and its upstream SH2/SH3 adaptor Grb2 in
directing the differentiation of murine embryonic stem cells
(mESCs) into primitive endoderm (PrE; Cheng et al., 1998).
During early mammalian development, the inner cell mass
(ICM) differentiates into epiblast, which gives rise to the embryo
proper, and PrE, an essential extraembryonic lineage. PrE differ-
entiation is induced by fibroblast growth factor 4 (FGF4; Feld-
man et al., 1995) and its cognate receptor tyrosine kinase
(RTK) FGF receptor 2 (FGFR2; Arman et al., 1998), which in
turn transmits a phosphotyrosine (pTyr)-based signal through
Grb2 to Sos proteins and thus to the Ras-Erk pathway (Cheng
et al., 1998; Hamazaki et al., 2006). This signal initiates PrE
differentiation by creating ametastable state of the ICM, wherein
expression of the pluripotency factor Nanog is heterogeneous
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Figure 1. FGF4-Grb2 Signaling Generates a Metastable, ‘‘Primed’’
mESC State and Drives PrE Lineage Commitment
(A) Model of Sos1 activation; allosteric Ras (gray) and substrate Ras (white)
occupy different binding sites on the Sos1 RasGEF module.
(B) Model of PrE differentiation from mESCs. Grb2 signaling induces segre-
gation of mESCs into Nanog+ (red) and Dnmt3b+ (blue) subpopulations and
subsequent differentiation of the PrE lineage (GATA4+, purple).
(C) Grb2/ and WT mESCs stained for Nanog, Dnmt3b, Oct4, or GATA4
expression or giemsa stained.
(D) Nanog and Dnmt3b staining (top) and immunoblot analysis (bottom) of
Fgf4/ mESCs. FGF4 (100 ng/ml) and FGFRi (SU5402;10 mM) were added
for 48 hr prior to analysis.
(E) Giemsa staining (top) and GATA4 immunoblot analysis (bottom) of Fgf4/
mESCs following prolonged culture in the presence or absence of FGF4.
See also Figures S1 and S2.(Chazaud et al., 2006), a phenomenon we refer to as ‘‘priming.’’
In a similar vein, mESCs transit through a metastable primed
state of low Nanog expression prior to lineage commitment
(Chambers et al., 2007). Downregulation of Nanog allows for
upregulation of transcription factors, such as GATA6, that drive
expression of genes required for PrE differentiation, including
GATA4 (Morrisey et al., 1998; Soudais et al., 1995).
Metastable priming is lost in Grb2/ embryos and mESCs
(Chazaud et al., 2006; Hamazaki et al., 2006) but can be regen-
erated by expression of a chimeric protein in which a truncated
Sos1 polypeptide lacking the proline-rich C terminus that binds
the Grb2 SH3 domains is fused to the Grb2 SH2 domain
(Cheng et al., 1998). This Sos1-Grb2 chimera is directly
recruited to pTyr sites through its intrinsic Grb2 SH2 domain,
circumventing the requirement for Grb2 itself in early embryonic
development. In addition to the C-terminal Grb2-interaction
motifs, Sos1 has a Cdc25 domain that catalyzes the exchange
of guanosine diphosphate (GDP) for guanosine triphosphate
(GTP) on Ras, preceded by a Ras exchanger motif (REM),
which together form a RasGEF module that binds both
substrate Ras and a second, allosteric Ras molecule (Margarit
et al., 2003; see Figure 1A). The binding of Ras-GTP to the
allosteric site activates the Cdc25 domain, thereby creating
a positive feedback loop that sensitizes Sos1 to an initial burst
of Ras-GTP (Boykevisch et al., 2006). Sos1 also has a DH-PH
cassette, of which the PH domain binds to phospholipids
such as phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2;
Chen et al., 1997; Kubiseski et al., 1997). At the N terminus,
Sos1 possesses a histone folds (HF) domain with a basic
surface that binds membrane phospholipids (Yadav and Bar-
Sagi, 2010).
In the absence of growth factor stimulation, Sos1 is autoinhi-
bited by intramolecular interactions involving the DH-PH module
and HF domain (Gureasko et al., 2010; Sondermann et al.,
2004). Human SOS1 mutations from patients with Noonan
Syndrome (NS), a familial disorder caused by activating muta-
tions in the Ras-Erk pathway, drive signaling by disrupting the
autoinhibited conformation of SOS1 or increasing membrane
recruitment (Roberts et al., 2007; Tartaglia et al., 2007). Physio-
logical Sos1 activation following growth factor stimulation
occurs at the membrane through intermolecular interactions,
in which the C-terminal tail and the REM, PH, and HF domains
bind external ligands, thereby relieving autoinhibition and
driving Sos1 into an active configuration (reviewed in Findlay
and Pawson, 2008). Whether these protein-protein and
protein-lipid interactions are all required for Sos1 regulation in
a biological context and, if so, what functional advantage this
confers remain uncertain.
We have used the regeneration of PrE differentiation in
Grb2/ mESCs by the Sos1-Grb2 chimera as a system to
explore how the multiple protein- and phospholipid-interaction
domains of Sos1 and Grb2 regulate a key developmental
cell-fate decision. Our results indicate that these domains are
optimized not for maximal ligand affinity but to cooperatively
determine the timing and selectivity of cell-fate specification.
These data suggest a central mechanism through which the
acquisition of complex domain architectures could be advanta-
geous to multicellular organisms.Cell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc. 1009
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Figure 2. Identification of Grb2-Signaling Complexes that Regulate PrE Differentiation
(A) PCA plot of Grb2-interacting proteins quantified by SWATH-MS. The positions of the circles on the plot represent the relative behaviors of individual proteins
(see Table S1). Graphical data are average ± standard error of the mean (SEM) (n = 4).
(B) Cellomics analysis of Nanog/Dnmt3b expression in lentiviral shRNA-infected Sos1/ mESCs. Data shown are average ± standard deviation (SD) (n = 3).
(C) Giemsa staining of lentiviral shRNA-infected Sos1/ mESCs.
(D) Quantification of differentiated colonies in lentiviral shRNA-infected Sos1/ mESCs relative to shGFP control. Data shown are average ± SD (n = 3).
(legend continued on next page)
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RESULTS
Average Domain Complexity Has Increased from Yeast
to Higher Eukaryotes
The increased presence of multidomain proteins in metazoans
compared to yeast (Rubin et al., 2000) suggests that increasing
domain complexity has been selected for during evolution.
To quantify this within eukaryotes, we plotted the cumulative
distribution of the number of domains per protein across a
range of proteomes (Figure S1A available online). The cumulative
distribution span is shortest within the S. cerevisiae proteome
and increases in length throughout metazoans (Figure S1A;
average domains per protein, yeast = 1.9, human = 3.1), confirm-
ing that domain complexity increases throughout eukaryotic
evolution.
For any given signaling protein, it seems logical that acquiring
more domains (domain ‘‘accretion’’; Koonin et al., 2000) would
elevate its connectivity, providing a fitness advantage. A partic-
ular instance of domain accretion is given by comparing the
RasGEFs Cdc25p and SOS1, which activate the Ras GTPase
in yeast and human, respectively. Cdc25p contains only the
Cdc25 catalytic core and an SH3 domain (Figure S1B), whereas
human SOS1 consists of the REM-Cdc25 catalytic core, with
additional HF, DH, and PH domains, as well as proline-rich
motifs that connect to the SH2/SH3 adaptor protein Grb2. To
explore the biological importance of the various protein- and
lipid-interaction domains of Sos1 andGrb2, we investigated their
roles in the differentiation of mESCs to the essential PrE lineage
(Figure 1B).
A Physiological Assay for Grb2-Sos1 Signaling: The
Grb2-Sos1 RasGEF Complex Generates a Metastable
mESC State Primed for PrE Lineage Commitment
Wild-type (WT) mESC colonies display a heterogeneous Nanog
expression pattern, characteristic of the primed state, whereas
Grb2/mESCs are homogeneously Nanog positive (Figure 1C).
In WT mESCs, Nanog heterogeneity is accompanied by induc-
tion of the early PrE differentiation marker DNA methyltransfer-
ase 3b (Dnmt3b; Hirasawa and Sasaki, 2009), whereas Grb2/
mESCs have constitutively low Dnmt3b levels (Figure 1C). We
therefore examined whether Grb2 signaling generates a distinct
subpopulation of primed mESCs. On average, 47% of WT cells
were Nanog+, 52% were Dnmt3b+, and 1% were both Nanog+
and Dnmt3b+ (Figure S2A). By contrast, Grb2/ mESCs were
95% Nanog+/Dnmt3b, with the remaining 5% either Dnmt3b+
or Nanog+/Dnmt3b+. We also confirmed that autocrine FGF4
production is required for lineage priming. Indeed, Fgf4/
mESCs were largely Nanog+/Dnmt3b, and priming was
restored by incubation with FGF4 and reversed by the FGFR
inhibitor SU5402 (Figure 1D). These data suggest that mESCs
are primed for differentiation by segregating Nanog+ or Dnmt3b+
subpopulations in a fashion that depends on FGF4-Grb2
signaling.(E) Diagram of the Sos1-Grb2 chimera.
(F) Nanog and Dnmt3b levels in Grb2/ mESCs expressing Sos1-Grb2. Data sh
(G) Giemsa staining of Grb2/ mESCs expressing Grb2 or Sos1-Grb2.
See also Figure S3 and Table S1.Differentiation of primed cells to the PrE lineage, as monitored
by the expression of GATA4/6 PrE markers and formation of
a differentiated colony morphology, relies on Grb2 signaling
both in vitro and in the embryo (Chazaud et al., 2006; Figure 1B).
Grb2/ mESC colonies failed to differentiate PrE, as judged by
expression of the pluripotency marker Oct4, failure to induce
GATA4/6 PrE markers, and retention of an undifferentiated
colony morphology (Figures 1C and S2B). Similarly, Fgf4/
mESCs failed to induce GATA4 and retained an undifferentiated
morphology, which was rescued by addition of FGF4 (Figure 1E).
Following the creation of the primed mESC state, prolonged
FGF4-Grb2-dependent signaling is therefore required for PrE
lineage commitment.
To elucidate the biochemical mechanisms by which Grb2
transmits the prodifferentiative FGF4 signal in mESCs, we used
a proteomics technique termed Single Window Acquisition of
all Theoretical spectra Mass-Spectrometry (SWATH-MS; Gillet
et al., 2012) to quantify changes in Grb2-interacting proteins
following blockade of either FGFR or epidermal growth factor
receptor (EGFR) kinase activity in mESCs (Figure S3A). We em-
ployed principal-component analysis (PCA) of quantitative
SWATH data to identify subsets of proteins that behaved simi-
larly in their interaction with Grb2 following RTK inhibition (Fig-
ure 2A). This revealed that the scaffold protein Frs2 and the
tyrosine phosphatase Ptpn11 associate with Grb2 in mESCs in
a fashion that was selectively suppressed by the FGFR inhibitor
SU5402, whereas binding of Grb2 to Shc1 and Snx18 was
primarily lost upon treatment with the EGFR inhibitor AG1478
(Figure 2A). As tyrosine phosphorylation of Frs2 and Ptpn11
creates binding sites for the Grb2 SH2 domain (Hadari et al.,
1998; Kouhara et al., 1997), Frs2 and Ptpn11 appear to be the
major upstream docking proteins for Grb2 in FGF-stimulated
mESCs.We also identified a number of knownGrb2 SH3 domain
effectors, including Sos1, Sos2, Gab1, Cbl, and Cblb (Figure 2A).
Interaction of Grb2 with Sos1 was largely unperturbed by RTK
inhibition, suggesting that the stoichiometry of the Grb2/Sos1
complex is not significantly altered by EGFR or FGFR activity
in mESCs. We went on to confirm that Sos proteins are required
for PrE differentiation. Sos1/ embryos and mESCs differen-
tiate normally (Wang et al., 1997), likely as a result of increased
Sos2 expression (Figure S3B). However, silencing Sos2 expres-
sion in Sos1/ mESCs inhibited priming (Figures 2B and S3C)
and PrE differentiation (Figures 2C, 2D, S3D, and S3E), indicating
that Sos1/2 act as effectors of Grb2 during PrE lineage
specification.
Synthetic Biology Reveals that Multiple Sos1/Grb2
Ligand-Binding Domains Cooperate in PrE Lineage
Commitment
To address the roles of the various Sos1 interaction domains in
PrE specification, we examined mESC lineage priming and
commitment induced by the Sos1-Grb2 chimera (Figure 2E).
Expression of Sos1-Grb2 restored Grb2/ mESCs to aown are average ± SD (n = 3).
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Figure 3. Sos1 Integrates Diverse Mem-
brane Signals via Modular Domains to
Control PrE Differentiation
(A) Sos1-Grb2 mutations. E108/K121 = HF domain
membrane interaction surface; K456/R459 = PH
domain PI(4,5)P2-binding site; L686/R687/W729 =
allosteric Ras-binding site.
(B) Dnmt3b levels in Grb2/ mESCs express-
ing WT or mutant Sos1-Grb2. Data shown are
average ± SD (n = 3).
(C) A PLCd PH domain was tethered to the Sos1-
Grb2 KR/EE PH mutant (right). Dnmt3b levels in
Grb2/mESCsexpressingSos1-Grb2WT,KR/EE
PHmutant, or PLCdPH-tetheredKR/EEPHmutant
(left) are shown. Data are average ± SD (n = 3).
(D) Quantification of differentiated colonies from
Grb2/mESCs expressing Grb2, WT Sos1-Grb2,
or mutant Sos1-Grb2. Data shown are average ±
SD (n = 3).
(E) GATA4 levels in Grb2/ mESCs expressing
Grb2, WT Sos1-Grb2, or mutant Sos1-Grb2.
(F) ppErk levels in Fgf4/ mESCs following FGF4
stimulation (100 ng/ml) in the presence or absence
of FGFRi (SU5402, 10 mM).
(G) ppErk levels in Grb2/mESCs expressing WT
or mutant Sos1-Grb2 following 10 min stimulation
with 100 ng/ml aFGF.
See also Figure S4.Nanog/Dnmt3b+ primed state (Figures 2F and S4A) and
rescued PrE differentiation (Figure 2G). Therefore, we expressed
ligand-binding domain mutants of Sos1-Grb2 (Figure 3A) in
Grb2/ mESCs and assessed their relative abilities to induce
cell-fate change.
Binding of the Sos1 PH domain to membrane phospholipids
such as PI(4,5)P2 is important for RasGEF signaling in vitro
(Gureasko et al., 2008). To test the physiological relevance1012 Cell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc.of such phospholipid recognition, we
mutated the Sos1 PH domain to disrupt
its interaction with PI(4,5)P2 (Figures 3A
and S4B). WT Sos1 PH domain bound
to soluble PI(4,5)P2 with a dissociation
constant (KD) of 29 ± 3.4 mM (Figure S4C).
An R459A PH mutant (Kubiseski
et al., 1997, henceforth PHR/A) increased
the KD for PI(4,5)P2 to 114 ± 12.6 mM,
whereas a combined K456E/R459E
substitution (Chen et al., 1997; henceforth
PH KR/EE) further increased the KD for
PI(4,5)P2 to > 230 mM (Figure S4C). The
PH R/A mutation had little effect on the
ability of Sos1-Grb2 to rescue induction
of Dnmt3b expression in Grb2/mESCs
(Figure 3B), consistent with its modest
effect on the Sos1 PH-PI(4,5)P2 interac-
tion. However, the PH KR/EE variant
markedly interfered with the rescue of
Dnmt3b expression by Sos1-Grb2,
indicating that the Sos1 PH-PI(4,5)P2
interaction may be important for priming of mESCs. To investi-
gate whether PI(4,5)P2 engagement by the Sos PH domain is
sufficient for mESC differentiation, we tethered the PI(4,5)P2-
specific PH domain of PLCd (Kavran et al., 1998) to Sos1-Grb2
PH KR/EE (Figure 3C). Addition of an ectopic PLCd PH domain
rescued priming by the inactive Sos1-Grb2 PH KR/EE mutant,
consistent with the notion that PI(4,5)P2 is a physiological Sos1
PH domain ligand in mESCs.
The interaction between Ras-GTP and the Sos1 RasGEF
module, via a pocket behind the catalytic site, allosterically stim-
ulates RasGEF activity (Margarit et al., 2003). This interaction is
abolished by a W729E mutation (henceforth ‘‘allo W/E’’) in the
REM domain, either alone or in combination with L686E/R687A
(henceforth ‘‘allo LRW/EAE’’) in the Cdc25 domain. Analysis of
Dnmt3b levels upon expression of either allo W/E or allo LRW/
EAE mutants of Sos1-Grb2 in Grb2/ mESCs indicated that
binding of allosteric Ras is essential for Sos1 to prime mESCs
for differentiation (Figure 3B).We also confirmed that a truncated
Sos1 protein lacking the SH2 domain of Sos1-Grb2 (Sos1DSH2),
whichcould therefore not be recruited topTyr sites, suchas those
in Frs2 and Ptpn11, was incapable of rescuing Dnmt3b induction
in Grb2/ mESCs (Figure 3B). Furthermore, restoration of
priming by full-length Grb2 was abolished by inactivating either
the Grb2 SH2 or N-terminal SH3 domain, supporting the idea
that Grb2 induces priming by coupling Sos1 to pTyr sites (Fig-
ure S4D). Modulation of Dnmt3b expression by these Sos1-
Grb2 or full-lengthGrb2mutantswas accompanied by reciprocal
regulation of Nanog expression (Figures S4D and S4E).
To extend this analysis to the level of cellular morphology, we
examined whether Sos1-Grb2 PH, REM/Cdc25, and SH2
domain-mediated interactions are similarly important for PrE
lineage commitment. Sos1-Grb2 expression and prolonged
clonal culture induced PrE differentiation in Grb2/ mESCs,
as measured by colony morphology (Figures 2G and 3D) and
GATA4 induction (Figure 3E). The PH R/A mutation in the Sos1
PH domain had a minor effect on PrE differentiation (Figures
3D and 3E), whereas PH KR/EE, which more strongly interfered
with phospholipid binding, abolished Sos1-Grb2-mediated PrE
differentiation. Similarly, blocking allosteric Ras binding to the
Sos1 RasGEF domain (allo W/E) prevented rescue of GATA4
induction and colony differentiation, as did removal of the Grb2
SH2 domain (Sos1DSH2). Similar results were obtained with
WT and PH KR/EE Sos1-Grb2 expressed at subendogenous
levels (Figure S4F). In summary, direct coupling of Sos1 to acti-
vated receptor complexes through Grb2, recognition of mem-
brane lipids such as PI(4,5)P2 by the PH domain, and binding
of Ras to the allosteric site are all indispensable for Sos1 to not
only prime mESCs for differentiation but also direct PrE lineage
commitment.
Autocrine FGF4 is proposed to specify PrE by activating the
downstream Ras-Erk pathway, which we confirmed by stimu-
lating Fgf4/mESCs with FGF4 (Figure 3F). We therefore inves-
tigated the effects of Sos1-Grb2 mutations on Erk activation in
FGF-stimulated Grb2/ mESCs. Control Grb2/ cells had
low levels of phosphorylated Erk, which was increased by
expression of WT Sos1-Grb2 (Figure 3G). Reduction of the
Sos1 PH domain-PI(4,5)P2 interaction with the PH R/A mutation
decreased, whereas the more severe PH KR/EE mutation abol-
ished, Erk phosphorylation. Similarly, inhibiting allosteric Ras
binding (allo W/E) or uncoupling Sos1-Grb2 recruitment to
pTyr sites (Sos1DSH2 mutant) prevented FGF-dependent Erk
activation (Figure 3G). This fully correlates with the relative capa-
bility of these Sos1-Grb2 mutants to regenerate PrE lineage
specification.
In order to more fully investigate the relationship between Erk
activation and mESC lineage commitment, we examinedDnmt3b induction kinetics upon addition of FGF4 to Fgf4/
mESCs. Strong Erk activation within 15 min was seen in
response to 10 ng/ml FGF4, and this efficiently induced Dnmt3b
from 8 hr onward. By contrast, 1 ng/ml FGF4 poorly induced Erk
activation and Dnmt3b expression (Figure S4G). Therefore,
the amplitude of acute Erk activation by FGF4 correlates with
lineage priming, consistent with our results using Sos1-Grb2
mutants. We also examined autocrine FGF4-mediated Erk
activation induced by Sos1-Grb2 expression in actively
differentiating mESCs. As anticipated, Erk activation was unde-
tectable in Grb2/mESCs. However, expression of Sos1-Grb2
rescued Erk activation in either primed or fully differentiated
Grb2/ mESCs, whereas expression of Sos1-Grb2 PH KR/EE
failed to restore Erk activation (Figure S4H), just as it failed to
restore either mESC priming or PrE specification. Collectively,
our data demonstrate that Sos1 activation in mESCs is tightly
controlled by combinatorial interactions with pTyr sites, PI(4,5)
P2, and allosteric Ras, and that each interaction is essential
for FGF-dependent Erk activation, mESC priming, and PrE
specification.
A Charge Neutralization Mechanism in the Sos1 HF
Domain Is Conserved to Prevent Inappropriate Sos1
Activation and Lineage Commitment
As well as its autoinhibitory function, the N-terminal HF domain
has been implicated in Sos1 activation via a putative membrane
phospholipid-interaction surface, containing a patch of basic
residues punctuated by a central acidic residue, E108 (Figure 4A;
Gureasko et al., 2010). E108 is mutated to lysine in NS, where-
upon Sos1 is activated by an increase in the affinity of the
HF domain for membranes (Yadav and Bar-Sagi, 2010). There-
fore, we examined the role of Sos1 HF domain-mediated
membrane interaction during mESC differentiation. Mutating
a key basic residue in the membrane-interaction surface
(K121E) diminished Dnmt3b induction by Sos1-Grb2 (Figure 4B)
and suppressed PrE specification (Figure S5A), suggesting that
membrane recognition by the HF domain plays a functional
role in PrE specification.
We also addressed the influence of the activating E108K
NS mutation on Sos1-Grb2 activity and mESC fate determina-
tion. When expressed in Grb2/ mESCs, Sos1-Grb2 E108K
induced elevated Erk activation compared to WT Sos1-Grb2
(Figure 4C). Incorporation of the K121E substitution into
E108K Sos1-Grb2 partially reversed the effect of the NS muta-
tion on Erk signaling, consistent with the view that hyperactiva-
tion of the E108K Sos1-Grb2 mutant occurs as a result of
increased electrostatic attraction between the HF domain and
the membrane.
We speculated that increased membrane binding induced
by the E108K HF mutation may subvert the requirement for
coincident interaction with multiple membrane-based ligands
to induce biological Sos1 activation. Indeed, incorporation of
E108K into the Sos1DSH2 variant, which is defective for Erk
activation because it cannot couple to pTyr sites, fully rescued
Erk activation in Grb2/ mESCs (Figure 4C), indicating that
increased membrane recruitment by the Sos1 HF domain
uncouples Sos1 from pTyr regulation. The E108K mutation
also increased Dnmt3b induction by the Sos1DSH2 mutantCell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc. 1013
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Dnmt3b Figure 4. Charge Neutralization in the HF
Domain Ensures Receptor-Dependent Sos1
Activation and Cell-Fate Determination
(A) Electrostatic potential of the membrane-inter-
acting surface of the Sos1 HF domain. Putative
membrane-interacting residues are labeled by an
asterisk (*).
(B) Dnmt3b levels in Grb2/ mESCs express-
ing WT or mutant Sos1-Grb2. Data shown are
average ± SD (n = 3); *p% 0.02.
(C) ppErk levels in Grb2/mESCs expressing WT
or mutant Sos1-Grb2.
(D) Dnmt3b levels in Grb2/ mESCs express-
ing WT or mutant Sos1-Grb2. Data shown are
average ± SD (n = 3).
(E) Cytosolic (left) and membrane (right) com-
partments of Grb2/ mESCs expressing WT or
mutant Sos1-Grb2. GAPDH and Src mark cytosol
and membrane, respectively.
(F) Dnmt3b levels in Grb2/ mESCs expressing
full-length WT or mutant SOS1 proteins. Inter-
vening lanes were removed.
See also Figure S5.from baseline to a level similar to that of WT Sos1-Grb2 (Fig-
ure 4D), and this was accompanied by Nanog suppression (Fig-
ure S5B). Following prolonged culture, GATA4 expression was
induced to levels similar to those inWT Sos1-Grb2, and differen-
tiated mESC colonies appeared (Figures S5C and S5D). We
conclude that the E108K HF variant activates Sos1-dependent
signaling, thereby aberrantly priming mESCs and driving PrE
differentiation in the absence of a pTyr-Grb2 input.
The WT Sos1 HF domain appears to have evolved limited, but
biologically optimized affinity toward membrane phospholipid
ligands so as to maintain responsiveness of Sos1 to FGFR2
activation. The importance of finely tuned membrane binding
by the Sos1HF domain is supported by the conservation of basic
residues fromC. elegans to human and of aspartate or glutamate
at the position corresponding to E108 in human SOS1 (Fig-
ure S5E) (Yadav and Bar-Sagi, 2010). We therefore propose
that one biological consequence of the invariant HF acidic1014 Cell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc.residue is to limit HF domain membrane
affinity, preventing Sos1 activation and
initiation of PrE differentiation in the
absence of an appropriate FGFR2-pTyr
signal.
In light of these findings, we directly
tested whether E108 restricts Sos1
membrane affinity in mESCs. Fraction-
ating extracts of Grb2/ mESCs ex-
pressing Sos1-Grb2 revealed that neither
WT Sos1-Grb2 nor Sos1DSH2 were
stably membrane associated (Figure 4E).
However, the Sos1-Grb2 E108K mutant
yielded a stable membrane-associated
pool, supporting the hypothesis that
charge neutralization by E108 attenuates
Sos1 HF domain membrane affinity,
thus maintaining the requirement for a
pTyr signal in PrE development.We also pursued the physiological relevance of charge
neutralization on the HF domain by examining the ability of full-
length SOS1 to prime Grb2/ mESCs for differentiation. SOS1
expressed very poorly in Grb2/ cells (data not shown). Thus,
we sensitized our assay using another NS mutation, R552G,
which destabilizes autoinhibitory interactions and hyperacti-
vates SOS1 only when it is on membranes (Gureasko et al.,
2008). As anticipated, expression of WT SOS1 or SOS1 R552G
failed to prime Grb2/ mESCs for differentiation (Figure 4F),
presumably because SOS1 is inefficiently recruited to
membranes in the absence of Grb2. By contrast, expressing
SOS1 containing both R552G and E108K NS mutations induced
Dnmt3b expression in Grb2/ mESCs (Figure 4F), indicating
that these cells are primed to differentiate in the absence of
a pTyr-Grb2 signal. These data show that charge neutralization
on the HF domain is required to properly regulate full-length
SOS1.
AB C
Figure 5. The Modular Interaction Domains
of Sos1 Control Cell Fate by Directly and
Indirectly Influencing Sos1 RasGEF Activity
(A) Measurement of Sos1 RasGEF activity by
NMR. (Left) Representative HSQC spectra show-
ing chemical shift changes between Ras Tyr157 in
the GDP- and GTPgS-bound conformations.
(Right) Chemical shifts were measured over time,
quantified, and plotted to determine relative Ras-
GEF activity of Sos1-Grb2 expressed in Grb2/
mESCs. Data shown are average ± SD (n = 2).
(B) Normalized rate of the GDP-GTP exchange
reaction on Ras. Data shown are average ± SD
(n = 2).
(C) Sos1-Grb2 expression from Grb2/ mESC
lysates used for NMR assays.Protein and Lipid Interactions Modulate Sos1-Signaling
Output in Embryonic Cells through Both Direct and
Indirect Effects on GEF Activity
The functionally important Sos1 interactions identified in
mESCs could potentially have a direct effect on Sos1 RasGEF
activity or influence Sos1 activity indirectly through membrane-
based interactions that colocalize Sos1 with its Ras GTPase
substrate. To distinguish these possibilities, we used an
NMR-based assay that monitors GEF-catalyzed exchange of
GDP for GTP on Ras. This assay is based on the principle
that conversion of 15N-labeled Ras-GDP to Ras-GTP in-
duces specific chemical-shift perturbations in the Ras 1H-15N
heteronuclear single quantum coherence (HSQC) spectrum, as
previously employed to monitor regulation of the Ras super-
family GTPases RhoA and Rheb (Gasmi-Seabrook et al.,
2010; Marshall et al., 2009). Identification and quantification of
peak intensities at these unique chemical shifts, exemplified by
Ras Tyr157 (Figure 5A), can be used to determine the rate of
conversion of Ras-GDP to Ras-GTP, enabling direct real-time
measurement of RasGEF activity. Uniquely, this assay provides
sufficient sensitivity to measure the GEF activity of Sos1 from
cell lysates.
In the absence of an added GEF and in the presence of an
excess of nonhydrolyzable GTPgS, Ras intrinsically exchanges
GDP for GTP with a half-time (T1/2) of 126.2 ± 19.0 min (Fig-
ure 5A). Addition of Grb2/ mESC lysate expressing WT
Sos1-Grb2 increased this rate of conversion (T1/2 = 38.6 ±
1.7 min; Figure 5A). However, neither the E108K HF domainCell 152, 1008–1020, Fmutation (T1/2 = 36.7 ± 0.9 min), the PH
KR/EE mutation (T1/2 = 37.6 ± 1.2 min),
nor SH2 domain removal (SosDSH2; T1/
2 = 42. ± 0.2 min) had a significant effect
on Sos1-Grb2 RasGEF activity, consis-
tent with the notion that these domains
function by juxtaposing Sos1 and Ras at
the membrane. In contrast, the allo W/E
mutation, which inhibits the interaction
of Ras-GTP with the allosteric site on
the RasGEF domain, suppressed the
ability of Sos1-Grb2 to catalyze GDP/
GTP exchange on Ras in Grb2/mESCs
(T1/2 = 82.9 ± 9.7 min). The normalized exchange rate and
expression level of each Sos1-Grb2 variant were confirmed
(Figures 5B and 5C). Together, these data argue that the various
interactions mediated by different Sos1 domains can regulate
Sos1 function either by directly modulating RasGEF activity, as
in the case of allosteric Ras binding, or by localizing the GEF to
its Ras substrate via membrane targeting without modifying
enzymatic activity per se, as in the case of the Sos1 HF and
PH domains and the Grb2 SH2 domain.
Physiological Grb2 SH2 Domain Ligand Affinity Is
Optimized for Appropriate PrE Lineage Commitment
Our demonstration that the HF domain of Sos1 has evolved
a mechanism to prevent inappropriate PrE differentiation in the
absence of physiological growth factor signals suggests that
other modular interaction domains required for Sos1 activation,
such as theGrb2 SH2 domain, might also be finely balancedwith
respect to their ligand affinities. We tested this notion with an
SH2 domain engineered for potently increased pTyr affinity
(Figure 6A) (Kaneko et al., 2012). This mutant is based on the
Src SH2 domain and contains substitutions in the pTyr-binding
pocket (threonine bC3 to valine, cysteine bC3 to alanine, and
lysine bD6 to leucine, collectively termed ‘‘gain of function’’
[GOF]; Figure S6A). Analogous mutants in the Grb2 SH2 domain
were unstable in cells (data not shown). Therefore, in order to
apply this GOF Src SH2 domain to Grb2-dependent mESC
differentiation, we exploited our previous observation that
substituting tryptophan for threonine at the EF1 position (Figuresebruary 28, 2013 ª2013 Elsevier Inc. 1015
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6A and S6A; termed ‘‘T/W’’) converts the Src SH2 domain-
binding properties to those of a Grb2 SH2 domain (Marengere
et al., 1994). By combining T/W and GOF mutations in the Src
SH2 domain, we obtained a synthetic Grb2-like SH2 domain
with increased pTyr-binding activity (Figure 6A).
We initially confirmed that these mutations alter SH2 ligand
binding in the predictedmanner. TheWT Src SH2 domain bound
modestly (KD 11.4 ± 2.4 mM; Figure S6B) to a pY392 Frs2
peptide, a putative ligand for Grb2 in mESCs (Figure 2A). The
T/W mutation reduced this KD to 1.4 ± 0.23 mM, consistent
with an increased selectivity for Grb2 SH2 ligands. Introduction
of the GOF mutations into the Src SH2 T/W mutant reduced
the KD of the SH2 domain for the Frs2 peptide by 35-fold to
41 ± 8 nM. The combined Grb2-like T/W;GOF Src SH2 domain
therefore shows a remarkable increase in binding to the Frs2
peptide. Surface plasmon resonance kinetic analysis indicated
an increased on-rate (>103) and decreased off-rate (0.143) for
binding of the Frs2 pY392 peptide ligand to Src SH2 T/W;GOF
compared to Src SH2 T/W (Figure S6C), explaining the striking
increase in affinity.
In order to test whether the GOF substitutions in the Grb2-like
Src SH2 domain increased coupling to endogenous pTyr sites in
mESCs, we examined the interaction of synthetic Grb2 proteins
consisting of a Grb2-like SH2 domain flanked by Grb2 SH3
domains (termed Grb2[Src SH2]; Figure 6B) with the Grb2 SH2
domain ligands identified in Figure 2A. With SWATH-MS
analysis, we found that Frs2, Ptpn11, Shc1, and Snx18 copreci-
pitated with Grb2[Src SH2 T/W] and bound much more strongly
to the Grb2[Src SH2 T/W;GOF] variant with increased pTyr-
binding activity (Figures 6C and S6D). In contrast, binding of
these Grb2 variants to Sos1 was independent of SH2 domain
ligand affinity. The enhanced in vitro pTyr-binding properties of
the Src SH2 T/W;GOF mutant domain are therefore replicated
in the context of a full-length synthetic Grb2 protein expressed
in mESCs.
We also investigated whether SH2 domain ligand affinity influ-
ences activation of the Erk pathway. Grb2/ mESCs did not
significantly activate Erk even in the presence of FGF, but
Grb2[Src SH2 T/W] expression rescued Erk activation by
FGF in a dose-dependent fashion (Figure 6D). Grb2[Src SH2
T/W;GOF] induced Erk activation in the absence of exogenous
FGF, which was not further increased upon FGF stimulation.
Grb2[Src SH2 T/W;GOF] also augmented the kinetic profile of
Erk activation (Figure S6E). Importantly, Erk activation by Grb2
[Src SH2 T/W;GOF] was blocked by the FGFR inhibitorFigure 6. Grb2 SH2 Domain Ligand Affinity Is Tuned to Prevent Precoc
(A) Generation of a Grb2-like SH2 superbinder. WT Src SH2 domain complexed w
Thr to Trp introduces a preference for Grb2 ligands (top; Kimber et al., 2000), wh
(bottom; Kaneko et al., 2012). The combination mutant is a high-affinity SH2 dom
(B) Synthetic Grb2 in which the SH2 domain is replaced by the Src SH2 T/W (Gr
(C) PCA plot of Grb2[Src SH2 T/W] and Grb2[Src SH2 T/W;GOF] interacting p
individual proteins (see Table S1). Graphical data are average ± SEM (n = 3).
(D) ppErk levels following 10 min aFGF stimulation of Grb2/ mESCs expressin
(E) Dnmt3b levels in Grb2/ mESCs expressing WT Grb2 or Grb2[Src SH2] pro
(F) GATA4 expression in day 9 Grb2/ mESCs expressing WT Grb2 or Grb2[Src
(G) Colony morphology of Grb2/ mESCs expressing WT Grb2 or Grb2[Src SH
(H) Dnmt3b levels in Grb2/ mESCs expressing Sos1-Grb2 and Sos1-Src chim
See also Figure S6 and Table S1.SU5402 (Figure S6E), consistent with the notion that pTyr-
binding affinity of the Grb2 SH2 domain is tuned to allow an
appropriate response to FGF stimulation. Intriguingly, phosphor-
ylation of Frs2 on Tyr196, a pYxN Grb2 SH2-binding site, was
increased in Grb2[Src SH2 T/W;GOF]-expressing cells (Fig-
ure S6E), indicating that the increased on-rate and decreased
off-rate of Src SH2 T/W;GOF toward SH2 ligands (Figure S6C)
may protect them from dephosphorylation. Taken together,
these results confirm that the Src SH2 T/W;GOF domain mark-
edly potentiates pTyr signaling and Erk activation.
Based on these observations, we asked whether increased
SH2 pTyr binding influences priming of Grb2/ mESCs ex-
pressing synthetic Grb2 proteins. Grb2[Src SH2 T/W;GOF]
significantly enhanced Dnmt3b induction compared with WT
Grb2 or Grb2[Src SH2 T/W] (Figures 6E and S6F), and this was
accompanied by Nanog suppression (Figure S6G). Similar
results were obtained with a Sos1 chimera incorporating the
GOF Grb2-like Src SH2 domain (Sos1-Src SH2; Figure S6H).
Finally, we measured whether increased Grb2 SH2 phospho-
peptide binding drives inappropriate PrE lineage commitment.
Grb2/ mESCs re-expressing WT Grb2 displayed a differenti-
ated colony morphology, accompanied by expression of the
PrE marker GATA4 by around day 13 (Figures 2G and 3E).
However, by day 9, no detectable GATA4 was expressed by
Grb2/ mESCs, or cells rescued with WT Grb2 or Grb2[Src
SH2 T/W] (Figure 6F), indicating a normal delay in PrE differenti-
ation. By contrast, cells expressing Grb2[Src SH2 T/W;GOF]
displayed high levels of GATA4 by day 9 (Figure 6F). Grb2/
mESC colonies expressing Grb2 or Grb2[Src SH2 T/W] proteins
also continued to display a packed, undifferentiated morphology
similar to that of control cells at day 9 (Figure 6G). However,
Grb2/mESCs expressing Grb2[Src SH2 T/W;GOF] developed
a differentiated morphology by this stage (Figure 6G). Our
data show that increased SH2 domain pTyr binding induces
precocious PrE differentiation, arguing that the WT Grb2 SH2
domain is biochemically restrained with respect to ligand affinity
and has been selected to control appropriate timing of biological
events such as embryonic PrE differentiation.
Our results suggest that the Sos1/Grb2 complex functions
as a finely tuned coincidence detector to ensure appropriate
initiation of cell-fate change. Consistent with this, the E108K
mutation, which increased the affinity of the Sos1 HF domain
for membranes, caused aberrant mESC priming in the absence
of Grb2 SH2 domain-mediated pTyr engagement (Figure 4).
One important prediction of our model is that reciprocallyious Differentiation
ith a pYEEI phosphopeptide (left; Waksman et al., 1993). Mutation of the EF1
ereas mutations in the pTyr-binding pocket increase SH2 domain pTyr affinity
ain with preference for Grb2 ligands (right). Green = WT residues; red = mutant.
b2-like SH2, white) or T/W;GOF (high-affinity Grb2-like SH2, red).
roteins quantified by SWATH-MS. Circles represent the relative behavior of
g Grb2[Src SH2] proteins.
teins. Data shown are average ± SD (n = 3); *p% 0.04.
SH2] proteins. Intervening lanes were removed.
2] proteins.
eras. Data shown are average ± SD (n = 3); *p% 0.05.
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Figure 7. Multiple Limited-Affinity Ligand Interactions Allow Sos1/
Grb2 to Appropriately Specify Biological Output
(A) Under resting conditions, the Sos1/Grb2 complex remains inactive in the
cytosol and does not induce stem cell differentiation.
(B and C) Incomplete cellular stimulation may result in some interaction of
Sos1/Grb2 with membrane ligands (B), but this is insufficient to induce stem
cell differentiation until a full signal is received (C), and all ligand binding
domains are occupied.
(D) E108K NS mutation in the HF domain increases the affinity of Sos1 for
membrane ligands and induces aberrant stem cell differentiation in the
absence of a pTyr signal.
1018 Cell 152, 1008–1020, February 28, 2013 ª2013 Elsevier Inc.altering the ligand affinities of this domain pair, i.e., increasing
Grb2 SH2 pTyr affinity while reducing HF membrane engage-
ment, will result in similarly inappropriate mESC differentiation.
As previously demonstrated, the Sos1-Grb2 K121E reduced
HF membrane affinity and inhibited mESC priming (Figure 6G).
However, increasing Grb2 SH2 ligand affinity (Sos1-Src SH2
T/W;GOF) initiated mESC differentiation even in the face of
reduced HF membrane engagement. Therefore, reciprocally
tuning ligand affinities of the Grb2 SH2 and Sos1 HF domains
elicits mESC fate change, despite incomplete ligand engage-
ment. We propose that the relatively modest binding properties
of the Sos1 HF and Grb2 SH2 domains form part of a larger
system of limited-affinity interactions to tightly control Sos1
activation, ensuring that PrE specification is initiated only
upon formation of multiple, coincident biological interactions
(Figure 7).
DISCUSSION
Evolution ofMultiple Sos1Protein- and Lipid-Interaction
Domains Forms an Integrated System to Ensure
Appropriate Induction of Cell-Fate Change
Comparison of eukaryotic protein sequences suggests that
metazoans have evolved proteins with increased domain
complexity. To understand the importance of multidomain orga-
nization for metazoan development, we investigated the extent
to which the Sos1 RasGEF integrates multiple protein-protein
and protein-lipid interactions to control an essential mammalian
morphogenetic process, the formation of PrE. Our data suggest
that Sos1 does not simply act as a RasGEF but has also evolved
as a coincidence detector, in which the affinity of each module
for its cognate ligand has been fine-tuned tomonitor the strength
and duration of upstream FGF signals. By reciprocally adjusting
ligand affinities of individual domains to induce inappropriate
cell-fate change, we demonstrate that multiple, balanced ligand
interactions within a single protein confer signaling fidelity. This
ensures appropriate timing of PrE specification by preventing
aberrant activation of the Ras-Erk pathway in pluripotent cells
and precocious differentiation of epiblast and PrE lineages (Fig-
ure 7). Moreover, the metazoan ability to differentiate distinct cell
types, such as epiblast and PrE, may have been facilitated by the
evolution of such sophisticated multidomain proteins.
Limited-Affinity Biomolecular Interactions CanMaintain
Signaling Specificity
This cooperative system of domain-based interactions depends
on the recruitment of Sos1 to pTyr ligands via the Grb2 adaptor
protein. The affinity of Grb2 for pTyr-containing sites has been
selected to safeguard against inappropriate lineage commitment
(Figure 6). Therefore, the Grb2-mediated recruitment of Sos1 to
activated receptors defines the timing of events in embryonic
development by tightly coupling PrE cell-fate determination to(E) Similarly, a Grb2 SH2 domain with increased pTyr affinity drives precocious
stem cell differentiation. Therefore, in order for multiple, coincident ligand
interactions to appropriately specify stem cell differentiation, individual ligand
affinities must be selected to remain below a certain threshold.
exposure of pluripotent cells to an appropriately strong and sus-
tained FGF stimulus. The affinity of theGrb2 SH2 domain for pTyr
sites therefore explains how a signaling pathway conveys
temporal regulation of cellular development.
As a corollary, Sos1 must otherwise have limited membrane
affinity to prevent spurious pTyr-independent activation. Indeed,
our results indicate that the HF membrane-interaction surface is
required for Sos1 activation and PrE specification (Figure 4)
but is not in itself sufficient to drive Sos1 activation in the
absence of Grb2 (Figure 3). However, a NS mutation in the
Sos1 HF domain (E108K) increases HF domain membrane
affinity (Figure 4) (Yadav and Bar-Sagi, 2010), uncoupling Sos1
activation and PrE differentiation fromGrb2-dependent receptor
recruitment. Therefore, the precise affinity of the HF domain for
phospholipids is critical in balancing the membrane association
that supports Sos1 activation, with a requirement for FGF stim-
ulation to switch on Sos1 RasGEF signaling (Figure 7).
In conclusion, we propose that signaling complexes such as
Sos1/Grb2, which control key cell-fate decisions requiring
precise temporal and spatial control, employ multiple biologi-
cally optimized interaction surfaces that together form a cooper-
ative signaling device. Thismay be a general regulatory principle.
Indeed, an example from yeast suggests that a membrane-
binding domain in the Ste5 scaffold protein has imperfections
that ensure that activation of the yeast mitogen-activated protein
kinase (MAPK) pathway is robustly controlled by mating phero-
mone (Winters et al., 2005). In the case of Sos1/Grb2, the
requirement for concomitant ligand binding by the HF, PH, and
RasGEF domains of Sos1 and SH2 domain of Grb2 to trigger
pathway activation provides a mechanism by which noise,
such as stochastic exposure to growth factors, can be buffered
and the timing of differentiation events in the sophisticated
process of embryogenesis enforced. Our findings illustrate
how the interplay between distinct interaction domains in
a protein such as Sos1 not only supports the transmission of
a biochemical signal but also ensures a robust response to
developmental cues at precisely the right time and with sufficient
specificity to safeguard against precocious and hence disas-
trous induction of cell-fate change.
EXPERIMENTAL PROCEDURES
ESC Culture
mESCs were cultured on gelatin under standard conditions. WT and Sos1/
mESCs were infected with lentivirus for 24 hr and selected with puromycin
after 48 hr. Grb2/mESCswere transfected using Lipofectamine LTX (Invitro-
gen) and selected with puromycin. Unless otherwise stated, Nanog and
Dnmt3b levels were determined by immunoblotting.
Immunostaining and Cellomics Analysis
Nanog/Dnmt3b immunostaining of WT, Grb2/, and Fgf4/ mESCs was
carried out by confocal microscopy, and that of Sos1/ mESCs was carried
out by the Cellomics automated platform (Thermo Scientific).
PrE Differentiation Assays
WT, Grb2/, Fgf4/, or Sos1/ mESCs were either cultured at clonal
density, electroporated or infected with lentiviral shRNAs, and selected with
puromycin after 24 hr. After 4 days, leukemia inhibitory factor (LIF) was with-
drawn from the media, and colonies were cultured further to induce PrE
differentiation.Immunoprecipitation
Grb2/ mESCs were lysed in FLAG IP-MS lysis buffer (Bisson et al., 2011),
and triple-FLAG-tagged proteins immunoprecipitated with FLAG-M2 Agarose
(Sigma-Aldrich). Immunoprecipitates were washed thoroughly prior to immu-
noblot analysis or trypsin digestion followed by mass spectrometry.
Fluorescence Polarization
GST Sos PH domains were incubated with 200 nM BODIPY-labeled soluble
PI(4,5)P2 derivative (GloPIPs BODIPY TMR-PI(4,5)P2; Echelon), and His-Src
SH2 domains were incubated with 20 nM FITC-labeled Frs2 pTyr392 peptide
(MHNpYVNTE) prior to fluorescence polarization measurements.
SH2 Domain NMR-Based RasGEF Assay
Lysates from Grb2/ mESCs transfected with Sos1-Grb2 were incubated
with isotopically labeled, GDP-bound 15N-Ras and 10-fold molar excess
GTPgS. Peak intensities were extracted from individual spectra to calculate
the GDP/GTPgS ratio and plotted against time.
Surface Plasmon Resonance Kinetic Analysis
Comparative evaluation of Src T/W and Src T/W;GOF SH2 domain binding
to a FRS2 pY392 peptide was performed with a BIAcore 3000 instrument
(Biacore Inc.).
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